CurrentEndo coverage · page 13 of 33

Cardiovascular Diabetology

Briefs 481–520 of 1,291 CurrentEndo has covered from this journal, newest publication first

Latest from Cardiovascular Diabetology

All coverage, newest first

Cardiovasc Diabetol2 May 2025
Integrating adipsin with novel cardiometabolic and inflammatory indices for enhanced early prediction of gestational diabetes mellitus: a prospective cohort study
Cohort studyDiabetes in pregnancy
Cardiovasc Diabetol26 Apr 2025
Cardiomyocyte-specific NHE1 overexpression confers protection against myocardial infarction during hyperglycemia
Mechanistic study
Cardiovasc Diabetol26 Apr 2025
Cardiorenal protection with dapagliflozin in patients with type 2 diabetes mellitus and chronic coronary syndrome undergoing percutaneous coronary intervention: a registry cross-sectional study
Cross-sectional studyT2D & other
Cardiovasc Diabetol26 Apr 2025
Association between atherogenic index of plasma with all-cause and cardiovascular mortality in individuals with Cardiovascular-Kidney-Metabolic syndrome
Cohort study
Cardiovasc Diabetol25 Apr 2025
The effect of empagliflozin on peripheral microvascular dysfunction in patients with heart failure with preserved ejection fraction
Research articleT2D & other
Cardiovasc Diabetol25 Apr 2025
Dyslipidemia and aging: the non-linear association between atherogenic index of plasma (AIP) and aging acceleration
Cross-sectional studyLipids & liver
Cardiovasc Diabetol25 Apr 2025
Association between stress hyperglycemia ratio (SHR) and long-term mortality in patients with ischemic stroke: a retrospective cohort study
Cohort study
Cardiovasc Diabetol24 Apr 2025
Association of stress hyperglycemia ratio with short-term and long-term prognosis in patients undergoing coronary artery bypass grafting across different glucose metabolism states: a large-scale cohort study
Cohort studyT2D & other
Cardiovasc Diabetol24 Apr 2025
Real-world effectiveness of adding newer generation GLP-1RA to SGLT2i in type 2 diabetes
Cohort studyT2D & other
Cardiovasc Diabetol23 Apr 2025
Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study
Cohort studyComplications
Cardiovasc Diabetol21 Apr 2025
Long-term impact of diabetes on mortality in patients undergoing unprotected left main PCI: a propensity score-matched analysis from the BIA-LM registry
Cohort studyT2D & other
Cardiovasc Diabetol18 Apr 2025
Sex differences in myocardial flow reserve among individuals with type 2 diabetes: insights from the DiaHeart study
Cross-sectional studyT2D & other
Cardiovasc Diabetol18 Apr 2025
Impact of diabetes and glycemic status on ventricular–arterial coupling in the general population
Cross-sectional studyT2D & other
Cardiovasc Diabetol18 Apr 2025
Chain effect of lifecourse reproductive characteristics and body fat and muscle on cardiovascular disease in women: a Mendelian randomization study
Research articleReproductive endocrine
Cardiovasc Diabetol18 Apr 2025
Exploring the effect of dapagliflozin on coronary inflammation in type 2 diabetes patients based on the coronary artery perivascular fat attenuation index
Cohort studyT2D & other
Cardiovasc Diabetol16 Apr 2025
The association between the triglyceride–glucose index and vulnerable plaques in patients with type 2 diabetes mellitus: insights from coronary computed tomography angiography
Cohort studyT2D & other
Cardiovasc Diabetol16 Apr 2025
Integrative metabolomics and genomics reveal molecular signatures for type 2 diabetes and its cardiovascular complications
Cross-sectional studyT2D & other
Cardiovasc Diabetol16 Apr 2025
A different perspective on studying stroke predictors: joint models for longitudinal and time-to-event data in a type 2 diabetes mellitus cohort
Diagnostic or prognostic studyT2D & other
Cardiovasc Diabetol16 Apr 2025
Association between atherogenic index of plasma and new-onset stroke in a population with cardiovascular-kidney-metabolic syndrome stages 0–3: insights from CHARLS
Cohort study
Cardiovasc Diabetol16 Apr 2025
Joint association of triglyceride glucose index (TyG) and body roundness index (BRI) with stroke incidence: a national cohort study
Cohort study
Cardiovasc Diabetol16 Apr 2025
Estimated glucose disposal rate outperforms other insulin resistance surrogates in predicting incident cardiovascular diseases in cardiovascular-kidney-metabolic syndrome stages 0–3 and the development of a machine learning prediction model: a nationwide prospective cohort study
Cohort study
Cardiovasc Diabetol15 Apr 2025
Association between systemic inflammation biomarkers and incident cardiovascular disease in 423,701 individuals: evidence from the UK biobank cohort
Cohort study
Cardiovasc Diabetol13 Apr 2025
Insulin resistance quantified by estimated glucose disposal rate predicts cardiovascular disease incidence: a nationwide prospective cohort study
Cohort study
Cardiovasc Diabetol9 Apr 2025
Preeclampsia as an independent predictor of atherosclerosis progression in women with type 1 diabetes: a 5-year prospective study
Cohort studyT1D
Cardiovasc Diabetol9 Apr 2025
Combined effect of skeletal muscle mass loss and elevated insulin resistance on heart failure risk in older adults: a community-based longitudinal cohort study
Cohort study
Cardiovasc Diabetol5 Apr 2025
Temporal prevalence and prognostic impact of diabetes mellitus and albuminuria in heart failure with preserved ejection fraction
Cohort studyComplications
Cardiovasc Diabetol3 Apr 2025
Associations between cardiometabolic indices and the onset of metabolic dysfunction-associated steatotic liver disease as well as its progression to liver fibrosis: a cohort study
Cohort studyLipids & liver
Cardiovasc Diabetol2 Apr 2025
Elevated triglyceride-glucose index is a risk factor for cardiovascular events in adults with type 1 diabetes: a cohort study
Cohort studyT1D
Cardiovasc Diabetol2 Apr 2025
Improved prediction and risk stratification of major adverse cardiovascular events using an explainable machine learning approach combining plasma biomarkers and traditional risk factors
Diagnostic or prognostic study
Cardiovasc Diabetol2 Apr 2025
Incremental predictive value of liver fat fraction based on spectral detector CT for major adverse cardiovascular events in T2DM patients with suspected coronary artery disease
Cohort studyT2D & other
Cardiovasc Diabetol2 Apr 2025
Joint association of the triglyceride–glucose index and stress hyperglycemia ratio with incidence and mortality risks of new-onset atrial fibrillation during sepsis: a retrospective cohort study
Cohort study
Cardiovasc Diabetol2 Apr 2025
Lipidomic analysis reveals metabolism alteration associated with subclinical carotid atherosclerosis in type 2 diabetes
Cross-sectional studyComplications
Cardiovasc Diabetol2 Apr 2025
Relationship between hemoglobin glycation index and myocardial mechano-energetic efficiency in non-diabetic individual
Cross-sectional studyT2D & other
Cardiovasc Diabetol29 Mar 2025
Oxidative stress and inflammation mediate the adverse effects of cadmium exposure on all-cause and cause-specific mortality in patients with diabetes and prediabetes
Cohort studyT2D & other
Cardiovasc Diabetol29 Mar 2025
Anti-CD3 monoclonal antibody in treating patients with type 1 diabetes: an updated systematic review and meta-analysis
Meta-analysisT1D
Cardiovasc Diabetol29 Mar 2025
Joint association of estimated glucose disposal rate and systemic inflammation response index with mortality in cardiovascular-kidney-metabolic syndrome stage 0–3: a nationwide prospective cohort study
Cohort study
Cardiovasc Diabetol28 Mar 2025
Heart rate variability tests for diagnosing cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus in advanced stages of kidney disease
Diagnostic or prognostic studyComplications
Cardiovasc Diabetol28 Mar 2025
Pericoronary adipose tissue attenuation predicts compositional plaque changes: a 12-month longitudinal study in individuals with type 2 diabetes without symptoms or known coronary artery disease
Cohort studyT2D & other
Cardiovasc Diabetol26 Mar 2025
Early hemodynamic impact of SGLT2 inhibitors in overweight cardiometabolic heart failure: beyond fluid offloading to vascular adaptation– a preliminary report
Cohort studyObesity
Cardiovasc Diabetol26 Mar 2025
BMI-residualized data uncovers a cluster of people with type 2 diabetes and increased serum ferritin protected from cardiovascular disease
Cohort studyT2D & other

All 1,291 Briefs in ExploreShowing Briefs 481–520 of 1,291, newest first